![](/img/cover-not-exists.png)
P3. A soluble activin type II receptor prevents the development of myeloma bone disease
Andrew Chantry, Deborah Heath, Les Coulton, Holly Evans, Nicole Abdul, Jas Seehra, Karin Vanderkerken, Peter CroucherVolume:
34
Year:
2008
Language:
english
Pages:
15
DOI:
10.1016/j.ctrv.2008.03.044
File:
PDF, 39 KB
english, 2008